MYO - Myomo Inc Market Cap to Earnings and Growth Ratio

Brandmark of Myomo, Inc. (MYO)

Myomo, Inc. is developing a global distribution network for medical exoskeletons, relying on reliable suppliers of precision parts. Innovative arm recovery devices ensure high margins due to technological superiority. The growth-weighted P/E on the GURU.Markets chart demonstrates a fair market valuation, where the value of 0.00 reflects the metric's balance. The brand's pricing power is supported by the uniqueness of MyoPro and the prospects for insurance reimbursement.

MYO Myomo Inc PEG Multiple (07/04/2022 - 11/12/2026)
Finished products of Myomo

The PEG ratio compares the current P/E multiple with expected earnings growth, identifying asset undervaluation during periods of high expansion. Values below one signal growth potential, although they require verification of earnings forecasts to eliminate false signals. By analyzing the weighted price-to-earnings-to-growth ratio, an investor assesses the adequacy of the market value. For Myomo, Inc. (MYO), this indicator reflects the scaling efficiency of the robotic production of wearable medical devices.

Competing companies

Growth-Adjusted Market Cap to Net Income Boston Scientific Corp|Edwards Lifesciences Corp - Price/Earnings to Growth Multiple|RMD (ResMed Corporation) - Market Cap to Earnings and Growth Ratio|Insulet Corporation - PEG Multiple|Price to Earnings Adjusted for Growth Rate Zimmer Biomet Holdings Inc|COO: PEG Multiple|Growth-Adjusted P/E Ratio ALGN|Price/Earnings to Growth Multiple GMED|TMDX: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Alphatec Holdings, Inc. (ATEC)|Price/Earnings to Growth Multiple artivion.com AORT|PEG Multiple ENOV (Enovis)|Integra LifeSciences Corp (IART) - Price to Earnings Adjusted for Growth Rate|Motiva - PEG Multiple|BBNX (iLet Bionic Pancreas) - Growth-Adjusted P/E Ratio|IRMD: PEG Multiple|EMBC - Growth-Adjusted Market Cap to Net Income|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|Price/Earnings to Growth Multiple AxoGen Inc (AXGN)|PEG Multiple SIBN|PEG Multiple Orthofix Corp (OFIX)|Price/Earnings to Growth Ratio Bioventus Inc. BVS|OrthoPediatrics Corp - Price/Earnings to Growth Ratio|TMCI: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio SRTA (Blade Air Mobility)|CARL: PEG Multiple|Price to Earnings Adjusted for Growth Rate RxSight Ophthalmic (RXST)|Price/Earnings to Growth Ratio ClearPoint Neuro Inc.|STXS - Price to Net Income Growth Ratio|Price/Earnings to Growth Multiple STIM (Neuronetics)|PEG Multiple Sight Sciences Inc. (SGHT)|PEG Multiple OBIO (Orchestra BioMed)|Growth-Adjusted Market Cap to Net Income Anika Therapeutics Inc. (ANIK)|NSPR - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio ZJYL|vivani.com (VANI) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Xtant Medical|NMTC (NeuroOne Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Modular Med MODD|Price/Earnings to Growth Ratio Envoy Medical, Inc. (COCH)|vivoslife.com - Growth-Adjusted P/E Ratio|enVVeno Medical Corp. - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio SINT (Sintx Technologies Inc)|TNON - Price/Earnings to Growth Ratio|Lifeward Ltd. (LFWD) - Price/Earnings to Growth Multiple|AMIX (autonomix.com) - Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate invobioscience.com (IVF)|Price/Earnings to Growth Ratio Bone Biologics Corp|Price to Earnings Adjusted for Growth Rate Axonics Inc. AXNX|Price/Earnings to Growth Ratio Biolase, Inc. (BIOL)|Price/Earnings to Growth Multiple dynatronics.com DYNT|Price/Earnings to Growth Ratio Paragon 28 FNA|INVO Bioscience Inc. (INVO) - Price to Earnings Adjusted for Growth Rate